ISPC — iSpecimen Income Statement
0.000.00%
Last trade - 00:00- $3.12m
- $1.24m
- $9.29m
Annual income statement for iSpecimen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.18 | 11.1 | 10.4 | 9.93 | 9.29 |
| Cost of Revenue | |||||
| Gross Profit | 4.6 | 5.89 | 5.65 | 5.11 | 3.99 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 10.6 | 19.3 | 20.6 | 21.1 | 22 |
| Operating Profit | -2.41 | -8.14 | -10.2 | -11.2 | -12.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.65 | -8.96 | -10.2 | -11.1 | -12.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.65 | -8.96 | -10.2 | -11.1 | -12.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.65 | -8.96 | -10.2 | -11.1 | -12.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.65 | -8.96 | -10.2 | -11.1 | -12.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -14.3 | -15.5 | -22.3 | -24.6 | -17.1 |
| Dividends per Share |